SecurityUS03167DAQ79 / AMNEAL PHARMACEUTICALS LLC - 10.8295% 2028-05-04
InstitutionBlackrock Floating Rate Income Trust
Latest Disclosed Value $ 724,662
Blackrock Floating Rate Income Trust ownership in US03167DAQ79 / AMNEAL PHARMACEUTICALS LLC

2025-08-26 - Blackrock Floating Rate Income Trust has filed a NPORT-P form disclosing ownership of AMNEAL PHARMACEUTICALS LLC (US:US03167DAQ79) valued at $724,662 USD as of 2025-06-30. Blackrock Floating Rate Income Trust had filed a previous NPORT-P on 2025-05-28 disclosing shares of AMNEAL PHARMACEUTICALS LLC valued at of $729,741 USD. This represents a change in value of -0.69 percent during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 725 -0.69 0.2158
2025-05-28 2025-03-31 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 730 -1.75 0.2222
2025-02-25 2024-12-31 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 742 0.95 0.2317
2024-11-26 2024-09-30 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 735 0.00 0.2464
2024-08-26 2024-06-30 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 736 0.14 0.2546
2024-05-28 2024-03-31 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 735 0.96 0.2556
2024-02-26 2023-12-31 NP Amneal Pharmaceuticals LLC 2023 Term Loan B LON US03167DAQ79 728 0.2528
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.